Patent 10933015 was granted and assigned to Laboratorios Farmaceuticos Rovi on March, 2021 by the United States Patent and Trademark Office.
The present invention provides a composition suitable for forming an intramuscular implant. It comprises a biodegradable thermoplastic polymer of polylactic acid (PLA), DMSO and an aromatase inhibitor compound. The invention also provides a kit suitable for the in situ formation of the composition and its use as a medicine for treating cancer, especially breast cancer.